GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Additional Paid-In Capital

FibroBiologics (STU:SG0) Additional Paid-In Capital : €26.64 Mil(As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Additional Paid-In Capital?


FibroBiologics's quarterly additional paid-in capital declined from Sep. 2023 (€23.59 Mil) to Dec. 2023 (€23.48 Mil) but then increased from Dec. 2023 (€23.48 Mil) to Mar. 2024 (€26.64 Mil).

FibroBiologics's annual additional paid-in capital increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€2.28 Mil) and increased from Dec. 2022 (€2.28 Mil) to Dec. 2023 (€23.48 Mil).

FibroBiologics Additional Paid-In Capital Historical Data

The historical data trend for FibroBiologics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Additional Paid-In Capital Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Additional Paid-In Capital
- 2.28 23.48

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only - 21.97 23.59 23.48 26.64

FibroBiologics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

FibroBiologics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (STU:SG0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
FBLG:USA
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines